Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.34%67.53M | -16.87%62.05M | -1.36%63.77M | -12.61%290.69M | -7.44%76.91M | -10.84%74.49M | 74.64M | 64.65M | -6.89%332.65M | 83.09M |
| Cost of revenue | -9.46%53.46M | -21.50%45.69M | -4.21%49.59M | -14.93%230.05M | -9.10%61.04M | -15.09%59.04M | 58.21M | 51.77M | -2.56%270.41M | 67.15M |
| Gross profit | -8.90%14.07M | -0.47%16.36M | 10.06%14.18M | -2.56%60.64M | -0.44%15.87M | 10.26%15.45M | 16.44M | 12.88M | -21.97%62.24M | 15.94M |
| Operating expense | -9.00%7.64M | -2.17%8.06M | -4.15%7.63M | -0.49%32.44M | 0.58%7.84M | 22.89%8.4M | 8.24M | 7.96M | -12.06%32.6M | 7.79M |
| Selling and administrative expenses | -9.00%7.64M | -2.17%8.06M | -4.15%7.63M | -0.49%32.44M | 0.58%7.84M | 22.89%8.4M | --8.24M | --7.96M | 182.77%32.6M | --7.79M |
| -Selling and marketing expense | -25.90%2.5M | -5.48%3.14M | 5.89%3.09M | 6.91%12.8M | 48.60%3.18M | 30.76%3.37M | --3.32M | --2.92M | 90.42%11.97M | --2.14M |
| -General and administrative expense | 2.33%5.14M | 0.06%4.92M | -9.95%4.54M | -4.78%19.65M | -17.62%4.66M | 18.12%5.03M | --4.92M | --5.04M | 293.44%20.63M | --5.65M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | --1.23M | ---- | ---- | ---- |
| Operating profit | -8.78%6.43M | 1.24%8.3M | 33.06%6.55M | -4.85%28.2M | -1.41%8.03M | -1.76%7.05M | 8.2M | 4.92M | -30.58%29.64M | 8.15M |
| Net non-operating interest income (expenses) | 14.68%-1.07M | 30.49%-775K | 16.63%-832K | 10.68%-4.52M | 12.89%-1.15M | 26.90%-1.25M | -1.12M | -998K | -180.68%-5.06M | -1.32M |
| Non-operating interest expense | -14.68%1.07M | -30.49%775K | -16.63%832K | -10.68%4.52M | -12.89%1.15M | -26.90%1.25M | --1.12M | --998K | 109.93%5.06M | --1.32M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 108.33%52K | 105.68%71K | -26K | -3,426.09%-1.62M | 1.33M | -15,700.00%-624K | -1.25M | 0 | -100.52%-46K | 0 |
| Less:Write off | -108.33%-52K | -105.68%-71K | --26K | 3,426.09%1.62M | ---1.33M | 15,700.00%624K | --1.25M | --0 | 101.00%46K | --0 |
| Other non-operating income (expenses) | -103.29%-163K | 1,838.46%452K | 109.75%65K | 648.45%2.12M | -1,315.91%-2.14M | 237.49%4.95M | -26K | -667K | -172.15%-386K | 176K |
| Income before tax | -48.12%5.25M | 38.58%8.05M | 76.77%5.75M | 0.13%24.18M | -13.32%6.07M | 46.01%10.13M | 5.81M | 3.25M | -51.82%24.15M | 7.01M |
| Income tax | 0.34%2.33M | 32.24%2.1M | 21.26%1.44M | -7.41%6.52M | -20.70%1.66M | 4.64%2.32M | 1.59M | 1.19M | -25.60%7.04M | 2.1M |
| Net income | -62.54%2.92M | 40.97%5.94M | 108.77%4.31M | 3.23%17.66M | -10.17%4.41M | 65.48%7.8M | 4.22M | 2.06M | -57.38%17.11M | 4.91M |
| Net income continuous operations | -62.54%2.92M | 40.97%5.94M | 108.77%4.31M | 3.23%17.66M | -10.17%4.41M | 65.48%7.8M | --4.22M | --2.06M | -57.93%17.11M | --4.91M |
| Noncontrolling interests | -77.55%22K | -156.52%-13K | 110.20%5K | -77.44%176K | 102.24%271K | -27.41%98K | 23K | -49K | 780K | 134K |
| Net income attributable to the company | -62.35%2.9M | 42.06%5.96M | 103.69%4.3M | 7.09%17.48M | -13.32%4.14M | 68.22%7.71M | 4.19M | 2.11M | -59.33%16.33M | 4.77M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -62.35%2.9M | 42.06%5.96M | 103.69%4.3M | 7.09%17.48M | -13.32%4.14M | 68.22%7.71M | 4.19M | 2.11M | -59.33%16.33M | 4.77M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -62.25%0.0094 | 41.91%0.0193 | 85.33%0.0139 | 13.66%0.06 | -13.18%0.0134 | 68.12%0.0249 | 0.0136 | 0.0075 | -59.33%0.0528 | 0.0154 |
| Diluted earnings per share | -62.25%0.0094 | 41.91%0.0193 | 85.33%0.0139 | 13.66%0.06 | -13.18%0.0134 | 68.12%0.0249 | 0.0136 | 0.0075 | -59.33%0.0528 | 0.0154 |
| Dividend per share | 0.01 | 0.01 | 0.01 | 0.05 | 0.05 | |||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.